Effects of recombinant human elafin on the expression of inflammatory factors and NF-κB p65 protein in neonatal mice with bronchopulmonary dysplasia induced by chronic hyperoxia
Objective:To investigate the effects of recombinant human elafin on the expression of inflammatory factors and nuclear factor-κB(NF-κB) p65 protein in neonatal mice with bronchopulmonary dysplasia(BPD) induced by chronic hyperoxia. Methods:A total of 30 C57BL/6J neonatal mice within postnatal 24 hours were equally and randomly divided into three groups:air group,hyper-oxia+Lactated-Ringer(L/R)-treated group(O2+L/R group,L/R solution as vehicle),and hyperoxia+elafin-treated group(O2+elafin group). The O2+L/R group and the O2 +elafin group were exposed to 85% oxygen,while the air group was exposed to 21% oxygen(room air). At 21 days of treatment,the baseline lung function was determined;HE staining was used to observe the morphological changes of the lung tissue;the mRNA expression of inflammatory factors was determined by real-time polymerase chain reaction and the expression of NF-κB p65 protein was determined by Western blot. Results:Compared with the air group,the O2+L/R group had a significantly lower body weight[(7.85±0.24) g vs. (5.33±0.63) g,P=0.000)] and delayed lung development;in addition,the O2+L/R group had significantly higher expression of tumor necrosis factor-α(TNF-α) mRNA(P=0.000),interleukin-1β(IL-1β) mRNA(P=0.000),and NF-κB p65 protein(P=0.001),but significantly lower expression of interleukin-4(IL-4) mRNA(P=0.000) and inter-leukin-13(IL-13) mRNA(P=0.000). Compared with the O2+L/R group,the O2+elafin group had a significantly higher body weight(P=0.014) and relatively normal alveolar morphology;in addition,the O2+elafin group had significantly lower expression of TNF-α mRNA(P=0.011),IL-1β mRNA(P=0.000),and NF-κB p65 protein(P=0.001),but significantly higher expression of IL-4 mRNA(P=0.047) and IL-13 mRNA(P=0.000). Conclusion:Elafin can effectively alleviate hyperoxia-induced lung injury in mice. The mechanism of action may be related to the inhibition of NF-κB activation and the release of inflammatory factors.